Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Buzzard Pharmaceuticals AB
AB
Active
Org 5590736855
Skeppsbron 16, 111 30
Stockholm
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2016 · 9 years old
1-4 employees
Monitor
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Buzzard Pharmaceuticals AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
EBITDA
SEK millions
1M
0M
-1M
-3M
-4M
-1M
2021
-1M
0%
2022
1M
+200%
2023
0M
-100%
2024
-3M
-300%
2025
Income statement
SEK thousands
Item
2021
2022
2023
2024
2025
Revenue
0
0
0
0
0
Staff expenses
—
—
−1 247
−1 243
−1 249
EBITDA
−1 277
−875
1 010
321
−2 706
Depreciation & amort.
−1 468
−1 606
−1 349
−1 052
−1 125
EBIT
−2 745
−2 481
−339
−731
−3 832
Net financials
—
37
131
73
26
Profit before tax
−2 745
−2 444
−208
−658
−3 806
Tax
−0
−0
—
—
—
Net profit
−2 745
−2 444
−208
−658
−3 806
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
2025
Total assets
76 237
134 088
124 488
131 890
137 997
Equity
71 754
120 782
120 574
129 918
136 115
Long-term debt
0
0
—
—
—
Short-term debt
4 483
13 306
3 914
1 972
1 882
Total debt
4 483
13 306
3 914
1 972
1 882
Financial ratios
5-year trend
EBITDA margin
-270624800.0%
This company
15.8%
Market median
-1712815290% vs market
2021
2025
Equity ratio
98.6%
This company
38.2%
Market median
+158% vs market
2021
2025
Return on equity
-2.8%
This company
18.4%
Market median
-115% vs market
2021
2025
Net profit margin
-380577500.0%
This company
8.1%
Market median
-4698487754% vs market
2021
2025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2021
2025
Debt / equity
0.01×
This company
0.62×
Market median
+98% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
More on Buzzard Pharmaceuticals AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
